Bioeq AG
Martin Huber serves as the Managing Director at Bioeq AG since September 2020. Prior to this role, Martin held various positions at Hirslanden from September 2014 to September 2020, including Head Supply Chain Management and Leiter Zentrale Logistikplattform. From August 2011 to August 2014, Martin was the Head of Materials Management and Procurement Manager at AAE Ahaus Alstätter Eisenbahn AG. Earlier experiences include serving as Leiter Partnerbetreuung & Projektleiter Logistik-Transport at Migros-Genossenschafts-Bund from March 2006 to July 2011 and working at SBB Cargo as a Qualitätsmanager and Management-Trainee from August 2003 to February 2006. Martin holds a Master of Science in Business Administration from Lucerne University of Applied Sciences and Arts, a CAS in Leadership from Kalaidos Fachhochschule Schweiz, and a Master of Advanced Studies in Supply-Chain- & Operations-Management from ZHAW Zurich University of Applied Sciences.
This person is not in any teams
Bioeq AG
Bioeq AG is a Swiss biopharmaceutical joint venture backed by the leading biosimilar developers Polpharma Biologics Group and Formycon AG and is based in Zug. We license, develop and commercialise a biosimilar, which is a successor product of Lucentis® (ranibizumab), a successful branded biopharmaceutical. We are a young and dynamic company, supported by an international network of experts. Bioeq AG out-licenses its products to established international pharmaceutical companies who ensure local distribution in each territory.